nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3A—penis—Crohn's disease	0.104	0.276	CbGeAlD
Lithium—IMPA1—mouth—Crohn's disease	0.049	0.13	CbGeAlD
Lithium—IMPA1—lymphoid tissue—Crohn's disease	0.022	0.0582	CbGeAlD
Lithium—GSK3B—epithelium—Crohn's disease	0.021	0.0557	CbGeAlD
Lithium—IMPA2—skin of body—Crohn's disease	0.0204	0.054	CbGeAlD
Lithium—GSK3B—smooth muscle tissue—Crohn's disease	0.0202	0.0536	CbGeAlD
Lithium—IMPA2—mammalian vulva—Crohn's disease	0.0186	0.0492	CbGeAlD
Lithium—GSK3A—smooth muscle tissue—Crohn's disease	0.0176	0.0466	CbGeAlD
Lithium—IMPA2—digestive system—Crohn's disease	0.0163	0.0432	CbGeAlD
Lithium—GSK3B—lymphoid tissue—Crohn's disease	0.0162	0.0429	CbGeAlD
Lithium—GSK3B—digestive system—Crohn's disease	0.016	0.0423	CbGeAlD
Lithium—GSK3A—mammalian vulva—Crohn's disease	0.0158	0.042	CbGeAlD
Lithium—GSK3A—digestive system—Crohn's disease	0.0139	0.0368	CbGeAlD
Lithium—Myasthenia gravis—Azathioprine—Crohn's disease	0.0094	0.0689	CcSEcCtD
Lithium—IMPA2—lymph node—Crohn's disease	0.0093	0.0247	CbGeAlD
Lithium—GSK3B—lymph node—Crohn's disease	0.00912	0.0242	CbGeAlD
Lithium—GSK3A—lymph node—Crohn's disease	0.00793	0.021	CbGeAlD
Lithium—Exophthalmos—Prednisone—Crohn's disease	0.00637	0.0467	CcSEcCtD
Lithium—Benign intracranial hypertension—Prednisone—Crohn's disease	0.00415	0.0304	CcSEcCtD
Lithium—Papilloedema—Prednisone—Crohn's disease	0.00384	0.0281	CcSEcCtD
Lithium—Psoriasis—Mesalazine—Crohn's disease	0.00367	0.0269	CcSEcCtD
Lithium—Albuminuria—Mesalazine—Crohn's disease	0.00309	0.0226	CcSEcCtD
Lithium—Hyperthyroidism—Prednisone—Crohn's disease	0.00309	0.0226	CcSEcCtD
Lithium—Scotoma—Mesalazine—Crohn's disease	0.00304	0.0223	CcSEcCtD
Lithium—Intracranial pressure increased—Prednisone—Crohn's disease	0.00292	0.0214	CcSEcCtD
Lithium—Leukocytosis—Mesalazine—Crohn's disease	0.00245	0.018	CcSEcCtD
Lithium—Coma—Mesalazine—Crohn's disease	0.00211	0.0154	CcSEcCtD
Lithium—Hypertonia—Mesalazine—Crohn's disease	0.00202	0.0148	CcSEcCtD
Lithium—Optic neuritis—Prednisone—Crohn's disease	0.00198	0.0145	CcSEcCtD
Lithium—Hypothyroidism—Prednisone—Crohn's disease	0.0019	0.0139	CcSEcCtD
Lithium—Alopecia—Mercaptopurine—Crohn's disease	0.00189	0.0138	CcSEcCtD
Lithium—Thirst—Mesalazine—Crohn's disease	0.00176	0.0129	CcSEcCtD
Lithium—Lethargy—Mesalazine—Crohn's disease	0.00171	0.0125	CcSEcCtD
Lithium—Arthralgia—Mercaptopurine—Crohn's disease	0.00158	0.0116	CcSEcCtD
Lithium—Memory impairment—Prednisone—Crohn's disease	0.00156	0.0114	CcSEcCtD
Lithium—Dry skin—Mesalazine—Crohn's disease	0.00153	0.0112	CcSEcCtD
Lithium—Oedema—Mercaptopurine—Crohn's disease	0.00152	0.0111	CcSEcCtD
Lithium—Glycosuria—Prednisone—Crohn's disease	0.00151	0.011	CcSEcCtD
Lithium—Gastritis—Mesalazine—Crohn's disease	0.00148	0.0109	CcSEcCtD
Lithium—Anorexia—Mercaptopurine—Crohn's disease	0.00145	0.0106	CcSEcCtD
Lithium—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00138	0.0101	CcSEcCtD
Lithium—Decreased appetite—Mercaptopurine—Crohn's disease	0.00132	0.00966	CcSEcCtD
Lithium—Weight increased—Mesalazine—Crohn's disease	0.00132	0.00965	CcSEcCtD
Lithium—Weight decreased—Mesalazine—Crohn's disease	0.00131	0.0096	CcSEcCtD
Lithium—Leukocytosis—Prednisone—Crohn's disease	0.0013	0.00952	CcSEcCtD
Lithium—Body temperature increased—Mercaptopurine—Crohn's disease	0.0012	0.00879	CcSEcCtD
Lithium—Arrhythmia—Azathioprine—Crohn's disease	0.00114	0.00833	CcSEcCtD
Lithium—Alopecia—Azathioprine—Crohn's disease	0.00112	0.00824	CcSEcCtD
Lithium—Tinnitus—Mesalazine—Crohn's disease	0.00108	0.00792	CcSEcCtD
Lithium—Diarrhoea—Mercaptopurine—Crohn's disease	0.00104	0.0076	CcSEcCtD
Lithium—Alopecia—Mesalazine—Crohn's disease	0.00102	0.0075	CcSEcCtD
Lithium—Flatulence—Mesalazine—Crohn's disease	0.000994	0.00728	CcSEcCtD
Lithium—Dysgeusia—Mesalazine—Crohn's disease	0.000988	0.00724	CcSEcCtD
Lithium—Vomiting—Mercaptopurine—Crohn's disease	0.000964	0.00707	CcSEcCtD
Lithium—Rash—Mercaptopurine—Crohn's disease	0.000956	0.00701	CcSEcCtD
Lithium—Dermatitis—Mercaptopurine—Crohn's disease	0.000955	0.007	CcSEcCtD
Lithium—Vision blurred—Mesalazine—Crohn's disease	0.00095	0.00696	CcSEcCtD
Lithium—Tremor—Mesalazine—Crohn's disease	0.000945	0.00692	CcSEcCtD
Lithium—Arthralgia—Azathioprine—Crohn's disease	0.000943	0.00691	CcSEcCtD
Lithium—Discomfort—Azathioprine—Crohn's disease	0.000931	0.00682	CcSEcCtD
Lithium—Angioedema—Mesalazine—Crohn's disease	0.000921	0.00675	CcSEcCtD
Lithium—Vertigo—Mesalazine—Crohn's disease	0.000906	0.00664	CcSEcCtD
Lithium—Syncope—Mesalazine—Crohn's disease	0.000904	0.00663	CcSEcCtD
Lithium—Lethargy—Prednisone—Crohn's disease	0.000904	0.00663	CcSEcCtD
Lithium—Nausea—Mercaptopurine—Crohn's disease	0.000901	0.0066	CcSEcCtD
Lithium—Loss of consciousness—Mesalazine—Crohn's disease	0.000886	0.0065	CcSEcCtD
Lithium—Arthralgia—Mesalazine—Crohn's disease	0.000859	0.00629	CcSEcCtD
Lithium—Discomfort—Mesalazine—Crohn's disease	0.000848	0.00622	CcSEcCtD
Lithium—Hypotension—Azathioprine—Crohn's disease	0.000844	0.00619	CcSEcCtD
Lithium—Dry mouth—Mesalazine—Crohn's disease	0.00084	0.00615	CcSEcCtD
Lithium—Confusional state—Mesalazine—Crohn's disease	0.00083	0.00608	CcSEcCtD
Lithium—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000823	0.00603	CcSEcCtD
Lithium—Oedema—Mesalazine—Crohn's disease	0.000823	0.00603	CcSEcCtD
Lithium—Dry skin—Prednisone—Crohn's disease	0.000812	0.00595	CcSEcCtD
Lithium—Shock—Mesalazine—Crohn's disease	0.00081	0.00593	CcSEcCtD
Lithium—Anorexia—Mesalazine—Crohn's disease	0.000785	0.00575	CcSEcCtD
Lithium—Muscular weakness—Prednisone—Crohn's disease	0.000781	0.00573	CcSEcCtD
Lithium—Hypotension—Mesalazine—Crohn's disease	0.000769	0.00564	CcSEcCtD
Lithium—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00075	0.0055	CcSEcCtD
Lithium—Feeling abnormal—Azathioprine—Crohn's disease	0.000745	0.00546	CcSEcCtD
Lithium—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000739	0.00541	CcSEcCtD
Lithium—Somnolence—Mesalazine—Crohn's disease	0.000732	0.00536	CcSEcCtD
Lithium—Dyspepsia—Mesalazine—Crohn's disease	0.000724	0.00531	CcSEcCtD
Lithium—Decreased appetite—Mesalazine—Crohn's disease	0.000715	0.00524	CcSEcCtD
Lithium—Abdominal pain—Azathioprine—Crohn's disease	0.000714	0.00523	CcSEcCtD
Lithium—Body temperature increased—Azathioprine—Crohn's disease	0.000714	0.00523	CcSEcCtD
Lithium—Fatigue—Mesalazine—Crohn's disease	0.00071	0.0052	CcSEcCtD
Lithium—Erectile dysfunction—Prednisone—Crohn's disease	0.000705	0.00517	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—UBE2D1—Crohn's disease	0.000704	0.00145	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—TYK2—Crohn's disease	0.000702	0.00144	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—JAK2—Crohn's disease	0.000701	0.00144	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—TYK2—Crohn's disease	0.000698	0.00144	CbGpPWpGaD
Lithium—Weight increased—Prednisone—Crohn's disease	0.000697	0.00511	CcSEcCtD
Lithium—GSK3B—Signaling by ERBB2—TYK2—Crohn's disease	0.000695	0.00143	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TAGAP—Crohn's disease	0.000693	0.00143	CbGpPWpGaD
Lithium—Weight decreased—Prednisone—Crohn's disease	0.000693	0.00508	CcSEcCtD
Lithium—GSK3B—DAP12 signaling—TYK2—Crohn's disease	0.000691	0.00142	CbGpPWpGaD
Lithium—Hyperglycaemia—Prednisone—Crohn's disease	0.000691	0.00506	CcSEcCtD
Lithium—GSK3B—Innate Immune System—CCR6—Crohn's disease	0.000683	0.0014	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—RIPK2—Crohn's disease	0.000682	0.0014	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—ITGA4—Crohn's disease	0.000682	0.0014	CbGpPWpGaD
Lithium—Feeling abnormal—Mesalazine—Crohn's disease	0.000678	0.00497	CcSEcCtD
Lithium—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000673	0.00493	CcSEcCtD
Lithium—GSK3A—Innate Immune System—RASGRP1—Crohn's disease	0.00067	0.00138	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—JAK2—Crohn's disease	0.000669	0.00138	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—JAK2—Crohn's disease	0.000666	0.00137	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—STAT3—Crohn's disease	0.000665	0.00137	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—JAK2—Crohn's disease	0.000663	0.00136	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—JAK2—Crohn's disease	0.00066	0.00136	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TAB1—Crohn's disease	0.000656	0.00135	CbGpPWpGaD
Lithium—Abdominal pain—Mesalazine—Crohn's disease	0.000651	0.00477	CcSEcCtD
Lithium—Body temperature increased—Mesalazine—Crohn's disease	0.000651	0.00477	CcSEcCtD
Lithium—GSK3B—Signaling by FGFR in disease—TYK2—Crohn's disease	0.00065	0.00134	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—TYK2—Crohn's disease	0.00065	0.00134	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—TYK2—Crohn's disease	0.00065	0.00134	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—TYK2—Crohn's disease	0.000645	0.00133	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—NOD2—Crohn's disease	0.000644	0.00132	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—RASGRP1—Crohn's disease	0.000644	0.00132	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD79A—Crohn's disease	0.000642	0.00132	CbGpPWpGaD
Lithium—GSK3B—Disease—RSPO3—Crohn's disease	0.000639	0.00131	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—TYK2—Crohn's disease	0.000639	0.00131	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—TYK2—Crohn's disease	0.000636	0.00131	CbGpPWpGaD
Lithium—Bradycardia—Prednisone—Crohn's disease	0.000624	0.00457	CcSEcCtD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—JAK2—Crohn's disease	0.000621	0.00128	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—JAK2—Crohn's disease	0.000621	0.00128	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—JAK2—Crohn's disease	0.000621	0.00128	CbGpPWpGaD
Lithium—Diarrhoea—Azathioprine—Crohn's disease	0.000618	0.00453	CcSEcCtD
Lithium—GSK3A—Signaling by FGFR in disease—STAT3—Crohn's disease	0.000616	0.00127	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—JAK2—Crohn's disease	0.000615	0.00126	CbGpPWpGaD
Lithium—Hallucination—Prednisone—Crohn's disease	0.00061	0.00447	CcSEcCtD
Lithium—GSK3B—Signaling by EGFR in Cancer—JAK2—Crohn's disease	0.00061	0.00125	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—SOCS1—Crohn's disease	0.000607	0.00125	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—JAK2—Crohn's disease	0.000607	0.00125	CbGpPWpGaD
Lithium—GSK3B—Disease—SEL1L—Crohn's disease	0.000606	0.00125	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RSPO3—Crohn's disease	0.000606	0.00125	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—STAT3—Crohn's disease	0.000603	0.00124	CbGpPWpGaD
Lithium—GSK3B—Immune System—CARD9—Crohn's disease	0.0006	0.00123	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—TYK2—Crohn's disease	0.0006	0.00123	CbGpPWpGaD
Lithium—Dizziness—Azathioprine—Crohn's disease	0.000597	0.00438	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—RBX1—Crohn's disease	0.000593	0.00122	CbGpPWpGaD
Lithium—GSK3A—Disease—GCKR—Crohn's disease	0.000593	0.00122	CbGpPWpGaD
Lithium—GSK3A—Immune System—NOD1—Crohn's disease	0.000593	0.00122	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ACKR2—Crohn's disease	0.000591	0.00121	CbGpPWpGaD
Lithium—Asthenia—Mesalazine—Crohn's disease	0.00059	0.00433	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	0.000589	0.00121	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—SOCS1—Crohn's disease	0.000583	0.0012	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—TYK2—Crohn's disease	0.000576	0.00118	CbGpPWpGaD
Lithium—Vomiting—Azathioprine—Crohn's disease	0.000574	0.00421	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—SEL1L—Crohn's disease	0.000574	0.00118	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—JAK2—Crohn's disease	0.000572	0.00118	CbGpPWpGaD
Lithium—Rash—Azathioprine—Crohn's disease	0.00057	0.00417	CcSEcCtD
Lithium—Dermatitis—Azathioprine—Crohn's disease	0.000569	0.00417	CcSEcCtD
Lithium—Headache—Azathioprine—Crohn's disease	0.000566	0.00415	CcSEcCtD
Lithium—Diarrhoea—Mesalazine—Crohn's disease	0.000563	0.00413	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—MLN—Crohn's disease	0.00056	0.00115	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—JAK2—Crohn's disease	0.00055	0.00113	CbGpPWpGaD
Lithium—Arrhythmia—Prednisone—Crohn's disease	0.000548	0.00401	CcSEcCtD
Lithium—GSK3B—Signaling by SCF-KIT—STAT3—Crohn's disease	0.000546	0.00112	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	0.000546	0.00112	CbGpPWpGaD
Lithium—Dizziness—Mesalazine—Crohn's disease	0.000544	0.00399	CcSEcCtD
Lithium—GSK3B—Disease—LTF—Crohn's disease	0.000544	0.00112	CbGpPWpGaD
Lithium—Alopecia—Prednisone—Crohn's disease	0.000542	0.00397	CcSEcCtD
Lithium—GSK3B—Innate Immune System—UBE2D1—Crohn's disease	0.000542	0.00111	CbGpPWpGaD
Lithium—GSK3A—Immune System—CCR6—Crohn's disease	0.000538	0.00111	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—STAT3—Crohn's disease	0.000537	0.0011	CbGpPWpGaD
Lithium—Nausea—Azathioprine—Crohn's disease	0.000537	0.00393	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—CCR9—Crohn's disease	0.000525	0.00108	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—RIPK2—Crohn's disease	0.000525	0.00108	CbGpPWpGaD
Lithium—GSK3A—Disease—SLC11A1—Crohn's disease	0.000524	0.00108	CbGpPWpGaD
Lithium—Vomiting—Mesalazine—Crohn's disease	0.000523	0.00383	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—UBE2D1—Crohn's disease	0.00052	0.00107	CbGpPWpGaD
Lithium—Rash—Mesalazine—Crohn's disease	0.000519	0.0038	CcSEcCtD
Lithium—Dermatitis—Mesalazine—Crohn's disease	0.000518	0.0038	CcSEcCtD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—Crohn's disease	0.000516	0.00106	CbGpPWpGaD
Lithium—Headache—Mesalazine—Crohn's disease	0.000516	0.00378	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—TAGAP—Crohn's disease	0.000512	0.00105	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—RIPK2—Crohn's disease	0.000504	0.00104	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—ITGA4—Crohn's disease	0.000504	0.00104	CbGpPWpGaD
Lithium—Vision blurred—Prednisone—Crohn's disease	0.000503	0.00368	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000502	0.00103	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—RASGRP1—Crohn's disease	0.000495	0.00102	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—Crohn's disease	0.000494	0.00102	CbGpPWpGaD
Lithium—GSK3A—Immune System—PTPN2—Crohn's disease	0.000492	0.00101	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—STAT3—Crohn's disease	0.000491	0.00101	CbGpPWpGaD
Lithium—Agitation—Prednisone—Crohn's disease	0.00049	0.00359	CcSEcCtD
Lithium—Nausea—Mesalazine—Crohn's disease	0.000489	0.00358	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—GPR65—Crohn's disease	0.000488	0.001	CbGpPWpGaD
Lithium—Angioedema—Prednisone—Crohn's disease	0.000488	0.00357	CcSEcCtD
Lithium—GSK3A—Immune System—RBX1—Crohn's disease	0.000487	0.001	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—IL6—Crohn's disease	0.000486	0.001	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TAB1—Crohn's disease	0.000485	0.000996	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—Crohn's disease	0.000483	0.000993	CbGpPWpGaD
Lithium—Vertigo—Prednisone—Crohn's disease	0.000479	0.00351	CcSEcCtD
Lithium—Syncope—Prednisone—Crohn's disease	0.000478	0.00351	CcSEcCtD
Lithium—GSK3B—Innate Immune System—NOD2—Crohn's disease	0.000476	0.000979	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—RASGRP1—Crohn's disease	0.000476	0.000978	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD79A—Crohn's disease	0.000474	0.000975	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ALB—Crohn's disease	0.000471	0.000969	CbGpPWpGaD
Lithium—Loss of consciousness—Prednisone—Crohn's disease	0.000469	0.00344	CcSEcCtD
Lithium—GSK3A—Downstream signal transduction—IL6—Crohn's disease	0.000464	0.000955	CbGpPWpGaD
Lithium—Convulsion—Prednisone—Crohn's disease	0.000462	0.00339	CcSEcCtD
Lithium—GSK3A—Signaling by FGFR—IL6—Crohn's disease	0.000462	0.00095	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—Crohn's disease	0.00046	0.000946	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CRP—Crohn's disease	0.000458	0.000942	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—IL6—Crohn's disease	0.000458	0.000941	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—STAT3—Crohn's disease	0.000455	0.000937	CbGpPWpGaD
Lithium—Arthralgia—Prednisone—Crohn's disease	0.000454	0.00333	CcSEcCtD
Lithium—GSK3A—Disease—RBX1—Crohn's disease	0.000449	0.000924	CbGpPWpGaD
Lithium—GSK3A—Disease—HSPA1B—Crohn's disease	0.000449	0.000924	CbGpPWpGaD
Lithium—Discomfort—Prednisone—Crohn's disease	0.000449	0.00329	CcSEcCtD
Lithium—GSK3B—Innate Immune System—SOCS1—Crohn's disease	0.000449	0.000923	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RSPO3—Crohn's disease	0.000448	0.000921	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—STAT3—Crohn's disease	0.000445	0.000916	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—TYK2—Crohn's disease	0.000443	0.000911	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TLR4—Crohn's disease	0.000439	0.000903	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—SMAD3—Crohn's disease	0.000439	0.000902	CbGpPWpGaD
Lithium—GSK3B—Disease—GCKR—Crohn's disease	0.000438	0.000901	CbGpPWpGaD
Lithium—GSK3B—Immune System—NOD1—Crohn's disease	0.000438	0.000901	CbGpPWpGaD
Lithium—Oedema—Prednisone—Crohn's disease	0.000435	0.00319	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—SOCS1—Crohn's disease	0.000431	0.000886	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	0.000431	0.000885	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—Crohn's disease	0.000431	0.000885	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—Crohn's disease	0.000431	0.000885	CbGpPWpGaD
Lithium—Shock—Prednisone—Crohn's disease	0.000428	0.00314	CcSEcCtD
Lithium—GSK3A—Immune System—UBE2D1—Crohn's disease	0.000427	0.000878	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—Crohn's disease	0.000427	0.000877	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SEL1L—Crohn's disease	0.000424	0.000873	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—Crohn's disease	0.000423	0.00087	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—JAK2—Crohn's disease	0.000423	0.000869	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—Crohn's disease	0.000421	0.000866	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—STAT3—Crohn's disease	0.00042	0.000863	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ALB—Crohn's disease	0.00042	0.000863	CbGpPWpGaD
Lithium—Anorexia—Prednisone—Crohn's disease	0.000415	0.00304	CcSEcCtD
Lithium—GSK3A—Immune System—RIPK2—Crohn's disease	0.000414	0.000851	CbGpPWpGaD
Lithium—GSK3A—Immune System—ITGA4—Crohn's disease	0.000414	0.000851	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTGS2—Crohn's disease	0.000412	0.000847	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CXCL8—Crohn's disease	0.000411	0.000846	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—ICAM1—Crohn's disease	0.000404	0.000831	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL3—Crohn's disease	0.000404	0.00083	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	0.000403	0.000829	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—TYK2—Crohn's disease	0.000401	0.000825	CbGpPWpGaD
Lithium—GSK3B—Immune System—CCR6—Crohn's disease	0.000398	0.000818	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000397	0.00291	CcSEcCtD
Lithium—GSK3A—Disease—UBE2D1—Crohn's disease	0.000394	0.00081	CbGpPWpGaD
Lithium—GSK3A—Immune System—RASGRP1—Crohn's disease	0.00039	0.000803	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD79A—Crohn's disease	0.000389	0.0008	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR9—Crohn's disease	0.000388	0.000798	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC11A1—Crohn's disease	0.000387	0.000796	CbGpPWpGaD
Lithium—Dyspepsia—Prednisone—Crohn's disease	0.000383	0.00281	CcSEcCtD
Lithium—GSK3B—Axon guidance—JAK2—Crohn's disease	0.000383	0.000787	CbGpPWpGaD
Lithium—GSK3A—Immune System—TAB1—Crohn's disease	0.000382	0.000785	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—Crohn's disease	0.000382	0.000785	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	0.000381	0.000784	CbGpPWpGaD
Lithium—Decreased appetite—Prednisone—Crohn's disease	0.000379	0.00277	CcSEcCtD
Lithium—Fatigue—Prednisone—Crohn's disease	0.000375	0.00275	CcSEcCtD
Lithium—GSK3A—Immune System—NOD2—Crohn's disease	0.000375	0.000772	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTGS2—Crohn's disease	0.000367	0.000755	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—Crohn's disease	0.000365	0.000751	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTPN2—Crohn's disease	0.000364	0.000748	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GPR65—Crohn's disease	0.000361	0.000742	CbGpPWpGaD
Lithium—GSK3B—Immune System—RBX1—Crohn's disease	0.00036	0.00074	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—Crohn's disease	0.000359	0.000739	CbGpPWpGaD
Lithium—Feeling abnormal—Prednisone—Crohn's disease	0.000359	0.00263	CcSEcCtD
Lithium—Gastrointestinal pain—Prednisone—Crohn's disease	0.000356	0.00261	CcSEcCtD
Lithium—GSK3A—Immune System—SOCS1—Crohn's disease	0.000354	0.000727	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR6—Crohn's disease	0.000348	0.000716	CbGpPWpGaD
Lithium—Body temperature increased—Prednisone—Crohn's disease	0.000344	0.00252	CcSEcCtD
Lithium—Abdominal pain—Prednisone—Crohn's disease	0.000344	0.00252	CcSEcCtD
Lithium—GSK3B—Downstream signal transduction—IL6—Crohn's disease	0.000343	0.000706	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TYK2—Crohn's disease	0.000342	0.000703	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—Crohn's disease	0.000342	0.000702	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—Crohn's disease	0.00034	0.000699	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CRP—Crohn's disease	0.000338	0.000696	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—Crohn's disease	0.000338	0.000695	CbGpPWpGaD
Lithium—GSK3B—Disease—HSPA1B—Crohn's disease	0.000332	0.000683	CbGpPWpGaD
Lithium—GSK3B—Disease—RBX1—Crohn's disease	0.000332	0.000683	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—STAT3—Crohn's disease	0.000331	0.00068	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—JAK2—Crohn's disease	0.000326	0.000671	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TLR4—Crohn's disease	0.000324	0.000667	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL18—Crohn's disease	0.000318	0.000655	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—Crohn's disease	0.000318	0.000654	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	0.000318	0.000654	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—Crohn's disease	0.000318	0.000654	CbGpPWpGaD
Lithium—GSK3B—Immune System—UBE2D1—Crohn's disease	0.000315	0.000649	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—Crohn's disease	0.000315	0.000648	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RBX1—Crohn's disease	0.000315	0.000647	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—Crohn's disease	0.000313	0.000643	CbGpPWpGaD
Lithium—Asthenia—Prednisone—Crohn's disease	0.000312	0.00229	CcSEcCtD
Lithium—GSK3B—Signaling by PDGF—IL6—Crohn's disease	0.000311	0.00064	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—STAT3—Crohn's disease	0.00031	0.000638	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD4—Crohn's disease	0.000309	0.000636	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTGER4—Crohn's disease	0.000306	0.00063	CbGpPWpGaD
Lithium—GSK3B—Immune System—ITGA4—Crohn's disease	0.000306	0.000629	CbGpPWpGaD
Lithium—GSK3B—Immune System—RIPK2—Crohn's disease	0.000306	0.000629	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—ICAM1—Crohn's disease	0.000299	0.000614	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL3—Crohn's disease	0.000298	0.000613	CbGpPWpGaD
Lithium—Diarrhoea—Prednisone—Crohn's disease	0.000298	0.00218	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—CD4—Crohn's disease	0.000297	0.000611	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—Crohn's disease	0.000293	0.000603	CbGpPWpGaD
Lithium—GSK3B—Disease—UBE2D1—Crohn's disease	0.000291	0.000599	CbGpPWpGaD
Lithium—GSK3B—Immune System—RASGRP1—Crohn's disease	0.000288	0.000593	CbGpPWpGaD
Lithium—Dizziness—Prednisone—Crohn's disease	0.000288	0.00211	CcSEcCtD
Lithium—GSK3B—Immune System—CD79A—Crohn's disease	0.000288	0.000591	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—Crohn's disease	0.000287	0.000591	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TYK2—Crohn's disease	0.000286	0.000588	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2RA—Crohn's disease	0.000283	0.000581	CbGpPWpGaD
Lithium—GSK3B—Immune System—TAB1—Crohn's disease	0.000282	0.00058	CbGpPWpGaD
Lithium—GSK3A—Disease—SMAD3—Crohn's disease	0.000282	0.00058	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	0.000282	0.000579	CbGpPWpGaD
Lithium—GSK3B—Immune System—NOD2—Crohn's disease	0.000277	0.00057	CbGpPWpGaD
Lithium—Vomiting—Prednisone—Crohn's disease	0.000277	0.00203	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—UBE2D1—Crohn's disease	0.000276	0.000567	CbGpPWpGaD
Lithium—Rash—Prednisone—Crohn's disease	0.000275	0.00201	CcSEcCtD
Lithium—Dermatitis—Prednisone—Crohn's disease	0.000274	0.00201	CcSEcCtD
Lithium—GSK3B—Developmental Biology—JAK2—Crohn's disease	0.000273	0.000561	CbGpPWpGaD
Lithium—Headache—Prednisone—Crohn's disease	0.000273	0.002	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—RIPK2—Crohn's disease	0.000268	0.00055	CbGpPWpGaD
Lithium—GSK3A—Immune System—CRP—Crohn's disease	0.000267	0.000548	CbGpPWpGaD
Lithium—GSK3B—Immune System—SOCS1—Crohn's disease	0.000261	0.000537	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL3—Crohn's disease	0.000261	0.000537	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CXCL8—Crohn's disease	0.00026	0.000535	CbGpPWpGaD
Lithium—Nausea—Prednisone—Crohn's disease	0.000259	0.0019	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—CCR6—Crohn's disease	0.000257	0.000529	CbGpPWpGaD
Lithium—GSK3A—Immune System—TLR4—Crohn's disease	0.000256	0.000526	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TYK2—Crohn's disease	0.000253	0.00052	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RASGRP1—Crohn's disease	0.000252	0.000519	CbGpPWpGaD
Lithium—GSK3A—Immune System—ICAM1—Crohn's disease	0.000245	0.000504	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—JAK2—Crohn's disease	0.000241	0.000496	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL18—Crohn's disease	0.000235	0.000484	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RBX1—Crohn's disease	0.000233	0.000478	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—Crohn's disease	0.000231	0.000475	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SOCS1—Crohn's disease	0.000229	0.00047	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD4—Crohn's disease	0.000229	0.00047	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTGER4—Crohn's disease	0.000226	0.000466	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD4—Crohn's disease	0.000219	0.000451	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—Crohn's disease	0.000217	0.000446	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2RA—Crohn's disease	0.000209	0.00043	CbGpPWpGaD
Lithium—GSK3B—Disease—SMAD3—Crohn's disease	0.000208	0.000428	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—UBE2D1—Crohn's disease	0.000204	0.000419	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—STAT3—Crohn's disease	0.0002	0.000412	CbGpPWpGaD
Lithium—GSK3A—Immune System—TYK2—Crohn's disease	0.000199	0.00041	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RIPK2—Crohn's disease	0.000198	0.000407	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SMAD3—Crohn's disease	0.000197	0.000406	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—Crohn's disease	0.000197	0.000405	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—Crohn's disease	0.000196	0.000403	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL3—Crohn's disease	0.000193	0.000397	CbGpPWpGaD
Lithium—GSK3A—Immune System—JAK2—Crohn's disease	0.00019	0.000391	CbGpPWpGaD
Lithium—GSK3B—Immune System—TLR4—Crohn's disease	0.000189	0.000389	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNG—Crohn's disease	0.000187	0.000384	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RASGRP1—Crohn's disease	0.000187	0.000383	CbGpPWpGaD
Lithium—GSK3A—Disease—TYK2—Crohn's disease	0.000184	0.000378	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2RA—Crohn's disease	0.000183	0.000376	CbGpPWpGaD
Lithium—GSK3B—Immune System—ICAM1—Crohn's disease	0.000181	0.000372	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD4—Crohn's disease	0.00018	0.00037	CbGpPWpGaD
Lithium—GSK3A—Disease—JAK2—Crohn's disease	0.000175	0.000361	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—Crohn's disease	0.000173	0.000357	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SOCS1—Crohn's disease	0.000169	0.000347	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—Crohn's disease	0.000167	0.000344	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—Crohn's disease	0.000166	0.000342	CbGpPWpGaD
Lithium—GSK3A—Disease—CD4—Crohn's disease	0.000166	0.000342	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—Crohn's disease	0.000165	0.00034	CbGpPWpGaD
Lithium—GSK3B—Immune System—TYK2—Crohn's disease	0.000147	0.000303	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SMAD3—Crohn's disease	0.000146	0.0003	CbGpPWpGaD
Lithium—GSK3B—Immune System—JAK2—Crohn's disease	0.00014	0.000289	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—Crohn's disease	0.00014	0.000288	CbGpPWpGaD
Lithium—GSK3A—Immune System—STAT3—Crohn's disease	0.000139	0.000287	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNG—Crohn's disease	0.000138	0.000283	CbGpPWpGaD
Lithium—GSK3B—Disease—TYK2—Crohn's disease	0.000136	0.000279	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2RA—Crohn's disease	0.000135	0.000278	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD4—Crohn's disease	0.000133	0.000274	CbGpPWpGaD
Lithium—GSK3B—Disease—JAK2—Crohn's disease	0.00013	0.000267	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TYK2—Crohn's disease	0.000129	0.000265	CbGpPWpGaD
Lithium—GSK3A—Disease—STAT3—Crohn's disease	0.000129	0.000265	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—Crohn's disease	0.000124	0.000254	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—Crohn's disease	0.000123	0.000253	CbGpPWpGaD
Lithium—GSK3B—Disease—CD4—Crohn's disease	0.000123	0.000253	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—JAK2—Crohn's disease	0.000123	0.000253	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—Crohn's disease	0.000122	0.000251	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL8—Crohn's disease	0.000112	0.000231	CbGpPWpGaD
Lithium—GSK3B—Immune System—STAT3—Crohn's disease	0.000103	0.000212	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—Crohn's disease	9.74e-05	0.0002	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TYK2—Crohn's disease	9.52e-05	0.000196	CbGpPWpGaD
Lithium—GSK3B—Disease—STAT3—Crohn's disease	9.52e-05	0.000196	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—JAK2—Crohn's disease	9.08e-05	0.000187	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT3—Crohn's disease	9.02e-05	0.000185	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—Crohn's disease	9e-05	0.000185	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL8—Crohn's disease	8.29e-05	0.00017	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—Crohn's disease	7.2e-05	0.000148	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT3—Crohn's disease	6.66e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—Crohn's disease	6.65e-05	0.000137	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—Crohn's disease	6.3e-05	0.00013	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—Crohn's disease	4.65e-05	9.57e-05	CbGpPWpGaD
